Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Niva Bupa Health Insurance Company Limited (NIVABUPA.NS)
Gurugram, HR, IN
Niva Bupa Health Insurance Company Limited provides health insurance products in India. It offers health insurance plans, such as individual, family, NRIs, senior citizens, personal accident, critical illness; travel insurance, including international and studying abroad insurance plans; and corporate insurance comprising group and start up health, group personal accident and OPD coverage, and group health insurance claim process. The company was formerly known as Max Bupa Health Insurance Company Limited and changed its name to Niva Bupa Health Insurance Company Limited in July 2021. The company was founded in 1947 and is based in Gurugram, India. Niva Bupa Health Insurance Company Limited is a subsidiary of Bupa Singapore Holdings Pte. Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.62% | +1.87% | +5.38% | +6.04% | +7.90% | +7.96% | -10.42% | +10.12% | +10.12% | +10.12% | +10.12% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 5 | 0 |
| Buy | 3 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%+17.6% ★ Q1'26: +7.6% (vs Q1'25)
-
EPS growth Insurance - Life: +13.4%-100.0%
-
FCF margin FCF growth · Insurance - Life: +31.7%+2.0% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Insurance - Life: +12.4%+1.9% Q1'26: +16.0% (vs Q1'25)
-
ROIC Insurance - Life: +1.0%+3.9% ★ Q1'26: +41.5% (vs Q1'25)
-
Share dilution Insurance - Life: +0.4%-100.0% ★
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×1.97× Q1'26: 0.18× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2025 actual |
Mar 2026 5 Rev. Ana. 4 EPS Ana. |
Mar 2027 4 Rev. Ana. 5 EPS Ana. |
Mar 2028 4 Rev. Ana. 7 EPS Ana. |
Mar 2029 4 Rev. Ana. 3 EPS Ana. |
Mar 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
56.91B
est: 55.95B (+1.7%)
|
69.73B
60.89B – 80.55B
+24.6% YoY
|
91.71B
89.06B – 94.37B
+31.5% YoY
|
113.80B
110.40B – 117.19B
+24.1% YoY
|
139.42B
134.79B – 144.05B
+22.5% YoY
|
182.12B
182.12B – 182.12B
+30.6% YoY
|
| EBITDA |
3.02B
est: 2.97B (+1.7%)
|
3.70B
3.23B – 4.27B
+24.6% YoY
|
4.86B
4.72B – 5.00B
+31.5% YoY
|
6.03B
5.85B – 6.21B
+24.1% YoY
|
7.39B
7.15B – 7.64B
+22.5% YoY
|
9.66B
9.66B – 9.66B
+30.6% YoY
|
| EBIT |
2.77B
est: 2.72B (+1.7%)
|
3.40B
2.97B – 3.92B
+24.6% YoY
|
4.47B
4.34B – 4.60B
+31.5% YoY
|
5.54B
5.38B – 5.71B
+24.1% YoY
|
6.79B
6.57B – 7.02B
+22.5% YoY
|
8.87B
8.87B – 8.87B
+30.6% YoY
|
| Net Income |
2.14B
est: 2.14B (0.0%)
|
762.32M
342.75M – 1.18B
-64.3% YoY
|
2.81B
2.38B – 3.10B
+268.8% YoY
|
4.63B
2.92B – 6.26B
+64.9% YoY
|
6.80B
5.08B – 7.42B
+46.7% YoY
|
9.96B
9.96B – 9.96B
+46.6% YoY
|
| SGA |
2.30B
est: 2.26B (+1.7%)
|
2.82B
2.46B – 3.25B
+24.6% YoY
|
3.70B
3.60B – 3.81B
+31.5% YoY
|
4.59B
4.46B – 4.73B
+24.1% YoY
|
5.63B
5.44B – 5.82B
+22.5% YoY
|
7.35B
7.35B – 7.35B
+30.6% YoY
|
| EPS |
1.22
est: 1.20 (+1.6%)
|
0.40
0.19 – 0.66
-66.4% YoY
|
1.63
1.34 – 1.74
+303.9% YoY
|
2.52
1.64 – 3.52
+54.8% YoY
|
3.62
2.85 – 4.17
+43.5% YoY
|
5.60
5.60 – 5.60
+54.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | B | 3/5 | 5/5 | 2/5 | 4/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings history not available.
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Matthews Emerging Markets Discovery Active ETF MEMS MEMS | 0.32% | 71.0K | 0.99% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Krishnan Ramachandran | MD, Chief Executive Officer & Executive Director | 116M | male |
| Vikas Jain | Executive Vice President & Chief Investment Officer | 7M | male |
| Bhabatosh Mishra | Director & Chief Operating Officer | — | — |
| Dhiresh Rustogi | Chief Technology Officer & Director | — | male |
| Nimish Agrawal | Director, Chief Marketing Officer & Head of Digital SBU | — | male |
| Rajat Bajaj | Director and Chief of Legal, Compliance, Secretarial & Regulatory Affairs | — | male |
| Tarun Katyal | Chief Sustainability & HR Officer and Director | — | male |
| Aparna Sharma | Company Secretary & Compliance Officer | — | female |
| Vishwanath Mahendra | Chief Financial Officer & Executive Director | — | male |
| Aseem Gupta | Head of Bancassurance and Alliances & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NIVABUPA.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
